Search

everythinglearnresearchcommunity

for

Search:↓

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Aging in hair follicle stem cells leads to hair graying, thinning, and loss.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

The study used monkeys to test a hair loss treatment called minoxidil, which showed positive results.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Minoxidil helps hair growth and prevents hair loss in androgenetic alopecia. It's safe and effective.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Hair transplantation effectively treats burn scar alopecia, improving self-esteem and confidence.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

The research suggests that SFRP2 and PTGDS proteins might be indicators of female pattern hair loss and could contribute to hair loss.

Minoxidil helps hair growth and boosts self-esteem in balding men.

Stopping minoxidil treatment resumes balding; continuous use needed for results.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.

Mast cells might contribute to hair loss by causing skin thickening.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.